Day: February 3, 2021

Catalyst Biosciences Presents Pre-clinical SQ Treatment of Bleeds Data from its Marzeptacog alfa (activated) (MarzAA) Program at the 14th Annual EAHAD Congress

SOUTH SAN FRANCISCO, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today presented positive pre-clinical data...

Aligos Therapeutics Presents Data for its Chronic Hepatitis B Drug Candidates at the 30th Annual Conference of the Asian Pacific Association for the Study of the Liver

SOUTH SAN FRANCISCO, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company...

Georgia Health Information Network Selects Velatura Public Benefit Corporation to Provide Advanced Technology Platform to Support Interoperability

ATLANTA, Feb. 03, 2021 (GLOBE NEWSWIRE) -- The Georgia Health Information Network (GaHIN), Georgia’s state-designated health information exchange (HIE), has...

error: Content is protected !!